Wikidata

(Q40174984)

English

Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment

scientific article published on 16 December 2006

In more languages

Statements

title
Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17276407
retrieved
18 September 2017
author name string
Canhua Huang
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17276407
retrieved
18 September 2017
Hiroshi Ida
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17276407
retrieved
18 September 2017
Kosei Ito
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17276407
retrieved
18 September 2017
Haiyuan Zhang
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
17276407
retrieved
18 September 2017
Yoshiaki Ito
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
17276407
retrieved
18 September 2017
publication date
16 December 2006
1 reference
stated in
Europe PubMed Central
PubMed ID
17276407
retrieved
18 September 2017
page(s)
990-1000
1 reference
stated in
Europe PubMed Central
PubMed ID
17276407
retrieved
18 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40174984&oldid=1888285783"